Klinefelter's syndrome no consistent change was seen, LH levels remaining high and not rising further; similarly TLS levels did not change significantly from basal. Discussion Basal measurements of LH and TLS are therefore of considerable value in the diagnosis of male hypogonadism. The HCG test gives further information on Leydig cell function. The most marked response in subjects with hypogonadism is seen in panhypopituitarism of recent onset. In patients with isolated gonadotrophin deficiency a smaller response to HCG was seen, as has been reported by Bardin et al. (1969) in subjects with the syndrome of gonadotrophin deficiency and hyposmia. Evidence is conflicting with regard to the testosterone response following HCG injection in Klinefelter's syndrome (Kirschner et al. 1965 , Hudson et al. 1967 , Paulsen et al. 1968 ). Our patients who were untreated showed a consistent rise in TLS which was comparable to that seen in isolated gonadotrophin deficiency. This suggests that despite high levels of circulating LH the Leydig cells are capable of further stimulation in this condition. Some patients with panhypopituitarism or isolated gonadotrophin deficiency have basal LH levels that are only marginally low. In these subjects the absence of response to clomiphene differentiates them from normals, and enables a firm diagnosis to be made. The normal increase in LH and testosterone produced by clomiphene in men appears to be due to the-dhxginterfering with the normal testosterone feedback mechanism at hypothalamic level (Bardin et al. 1967 , Marshall et al. 1970 . In Klinefelter's syndrome, the high LH levels were not found to rise further on clomiphene. This indicates either that the feedback mechanism for testosterone is not functioning normally, or that their LH production is already maximal. diagnosed in any patient in whom a tumoui had been demonstrated, together with a plasma potassium of less than 3 mEq/l. and a bicarbonate greater than 30 mEq/I. prior to therapy, hyperglycxmia, and plasma cortisol of more than 40 ,ig/I00 ml with no nyctohemeral rhythm. Tissue was extracted by the method of Lyons (1937) and assayed by biological (Lipscomb & Nelson 1962) and radioimmunological methods, using two antiseraone reacting with a sequence within the biologically active N-terminal 24 amino acids, and the other reacting with the biologically inactive C-terminal part (amino acids 25-39). ACTH levels found in tumours associated with the ectopic ACTH syndrome are shown in Fig 1 and in the 'control' tumours in Fig 2. Bronchial carcinoids associated with the syndrome are clearly distinguished from 'controls' by their high values (> 1 ,ug/g) but there is no clear distinction between most oat cell ectopics and the 'control' tumour levels. The significance of the biological and immunological ACTH activity in the 'control' tumours is not clear but is unlikely to be due to sequestered blood. These tumours may be synthesizing ACTH but not releasing it at a rate sufficient to produce clinical evidence of metabolic disturbance. Other data are consistent with these findings (Liddle et al. 1969 ) and are compatible with this hypothesis (Werk et al. 1963) . It is of interest, but so far unexplained, that the ratio of Cto N-terminal tumour immunoactivity is much greater in the ectopic ACTH syndrome due to bronchial carcinoids than in that due to oat cell carcinoma of the bronchus. Much current work on the long-acting thyroid stimulator (LATS) is based on the ability of thyroid extracts to bind LATS. The absorbing or binding property of thyroid extracts is attributed to LATS-absorbing activity (LAA). It is hoped that purification of LAA may reveal the antigen to which LATS may be an antibody.
Absorption of LATS is usually demonstrated by comparing the responses to potent LATS sera with similar aliquots which have been incubated with thyroid extracts. When the commonly used McKenzie (1958) procedure is employed, LATS absorption is thus demonstrated (by the decline in LATS response) in mice which have been injected with a mixture of LATS and thyroid fractions containing LAA. Recently Florsheim et al. (1970) have shown that variations in the quantities of thyroxine administered or the injection of thyroglobulin-rich thyroid fractions in mice prepared for the McKenzie assay may inhibit the LATS response. They suggest that a critical evaluation of experiments claiming to demonstrate absorption of LATS is needed.
There are several lines of evidence which suggest that LATS is bound to LAA and that LATS absorption does truly occur:
(1) LAA can be isolated with a small proportion of the total thyroid protein in a 4S fraction which 'Present address: Department of Biochemistry, University of Toronto, Toronto 5, Ontario, Canada
